Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow 0.00% Nasdaq Up0.52%

More On NVC.V

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Neovasc Inc. (NVC.V)

-TSXV
6.40 Down 0.35(5.19%) 2:54PM EDT
Get the big picture on all your investments.
ProfileGet Profile for:
Neovasc Inc.
13700 Mayfield Place
Suite 2135
Richmond, BC V6V 2E4
Canada - Map
Phone: 604-270-4344
Fax: 604-270-4384
Website: http://www.neovasc.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Medical Appliances & Equipment
Full Time Employees:N/A

Business Summary 

Neovasc Inc., a specialty medical device company, develops, manufactures, and markets cardiovascular products worldwide. Its products include the Neovasc Reducer for the treatment of refractory angina; and Tiara technology in development for the transcatheter treatment of mitral valve disease. The company also develops and manufactures the PeriPatch, a line of biological tissue products for use in third-party medical products, including transcatheter heart valves. In addition, the company provides a range of custom Peripatch products to industry customers for incorporation into their own products; and consulting and original equipment manufacturing services to other medical device companies. Further, it offers pericardial tissue processing, vascular product development, design, and manufacturing solutions to industry partners. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Neovasc Inc.

Key Executives 
 PayExercised
Mr. Alexei J. Marko , 45
Chief Exec. Officer and Non-Independent Director
N/AN/A
Mr. Chris Clark CA, 42
Chief Financial Officer and Corp. Sec.
N/AN/A
Mr. Brian McPherson , 52
Chief Operating Officer and Pres of Neovasc Surgical
175.00KN/A
Ms. J. Caren Holtby ,
Investor Relations Mang.
N/AN/A
Ms. Cynthia A. Roney , 55
VP of Sales & Marketing
N/AN/A
Amounts are as of Dec 31, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in CAD.